title: Molecular dissection of the human alpha2-macroglobulin subunit reveals domains with antagonistic activities in cell signaling.
abstract: alpha(2)-Macroglobulin (alpha(2)M) is a plasma protease inhibitor, which reversibly binds growth factors and, in its activated form, binds to low density lipoprotein receptor-related protein (LRP-1), an endocytic receptor with cell signaling activity. Because distinct domains in alpha(2)M are responsible for its various functions, we hypothesized that the overall effects of alpha(2)M on cell physiology reflect the integrated activities of multiple domains, some of which may be antagonistic. To test this hypothesis, we expressed the growth factor carrier site and the LRP-1 recognition domain (RBD) as separate GST fusion proteins (FP3 and FP6, respectively). FP6 rapidly and robustly activated Akt and ERK/MAP kinase in Schwann cells and PC12 cells. This response was blocked by LRP-1 gene silencing or by co-incubation with the LRP-1 antagonist, receptor-associated protein. The activity of FP6 also was blocked by mutating Lys(1370) and Lys(1374), which precludes LRP-1 binding. FP3 blocked activation of Akt and ERK/MAP kinase in response to nerve growth factor-beta (NGF-beta) but not FP6. In PC12 cells, FP6 promoted neurite outgrowth and expression of growth-associated protein-43, whereas FP3 antagonized the same responses when NGF-beta was added. The ability of FP6 to trigger LRP-1-dependent cell signaling in PC12 cells was reproduced by the 18-kDa RBD, isolated from plasma-purified alpha(2)M by proteolysis and chromatography. We propose that the effects of intact alpha(2)M on cell physiology reflect the degree of penetration of activities associated with different domains, such as FP3 and FP6, which may be regulated asynchronously by conformational change and by other regulatory proteins in the cellular microenvironment.
authors.affiliation: Department of Pathology and Anesthesiology, University of California San Diego, La Jolla, CA 92093, USA.
authors.forename: Elisabetta
authors.initials: E
authors.lastname: Mantuano
authors.forename: Gatambwa
authors.initials: G
authors.lastname: Mukandala
authors.forename: Xiaoqing
authors.initials: X
authors.lastname: Li
authors.forename: W Marie
authors.initials: WM
authors.lastname: Campana
authors.forename: Steven L
authors.initials: SL
authors.lastname: Gonias
mesh_terms: D000818:Animals; D002460:Cell Line; D006801:Humans; D026503:Low Density Lipoprotein Receptor-Related Protein-1 / Q000235:genetics / Q000378:metabolism; D051379:Mice; D020928:Mitogen-Activated Protein Kinases / Q000235:genetics / Q000378:metabolism; D008970:Molecular Weight; D009154:Mutation / Q000235:genetics; D016501:Neurites / Q000187:drug effects / Q000378:metabolism; D011485:Protein Binding; D021122:Protein Subunits / Q000235:genetics / Q000378:metabolism / Q000494:pharmacology; D051381:Rats; D012583:Schwann Cells / Q000378:metabolism; D015398:Signal Transduction / Q000187:drug effects*; D000511:alpha-Macroglobulins / Q000235:genetics / Q000378:metabolism* / Q000494:pharmacology*
chemical_list: D026503:Low Density Lipoprotein Receptor-Related Protein-1; D021122:Protein Subunits; D000511:alpha-Macroglobulins; D020928:Mitogen-Activated Protein Kinases